ORPHENADRINE CITRATE - Generic Drug Details

What are the generic drug sources for orphenadrine citrate and what is the scope of freedom to operate?

Orphenadrine citrate is the generic ingredient in two branded drugs marketed by Pai Holdings Pharm, Hikma, Rising, Sagent Pharms, Watson Labs, Bausch, Ascot, Bayshore Pharms Llc, Impax Pharms, Lupin, and Sandoz, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for orphenadrine citrate. Nineteen suppliers are listed for this compound.

Summary for ORPHENADRINE CITRATE

US Patents:	0
Tradenames:	2
Applicants:	11
NDAs:	15
Drug Master File Entries:	8
Finished Product Suppliers / Packagers:	19
Raw Ingredient (Bulk) Api Vendors:	81
Patent Applications:	1,531
Drug Prices:	Drug price trends for ORPHENADRINE CITRATE
What excipients (inactive ingredients) are in ORPHENADRINE CITRATE?	ORPHENADRINE CITRATE excipients list
DailyMed Link:	ORPHENADRINE CITRATE at DailyMed

See drug prices for ORPHENADRINE CITRATE

Pharmacology for ORPHENADRINE CITRATE

Drug Class	Muscle Relaxant
Physiological Effect	Centrally-mediated Muscle Relaxation

US Patents and Regulatory Information for ORPHENADRINE CITRATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	ORPHENADRINE CITRATE	orphenadrine citrate	TABLET, EXTENDED RELEASE;ORAL	084303-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Lupin	ORPHENADRINE CITRATE	orphenadrine citrate	TABLET, EXTENDED RELEASE;ORAL	040284-001	Jun 19, 1998	AB	RX	No	Yes
Rising	ORPHENADRINE CITRATE	orphenadrine citrate	TABLET, EXTENDED RELEASE;ORAL	040249-001	Jan 29, 1999	AB	RX	No	No
Hikma	ORPHENADRINE CITRATE	orphenadrine citrate	INJECTABLE;INJECTION	040463-001	Mar 4, 2003	AP	RX	No	No
Sagent Pharms	ORPHENADRINE CITRATE	orphenadrine citrate	INJECTABLE;INJECTION	090585-001	Aug 30, 2011	AP	RX	No	No